Pharmaceutical

Coronado Research announce appointment of Dr. Jennifer Bradford as VP, Head of Data Science

LONDON, Dec. 12, 2024 /PRNewswire/ -- Coronado Research announced today that Dr. Jennifer Bradford has been appointed as VP, Head of…

1 year ago

Axtria Leads Frost & Sullivan’s First Pharmaceutical Commercialization Solutions and Services Industry Radar Report

BERKELEY HEIGHTS, N.J., Dec. 12, 2024 /PRNewswire/ -- Axtria Inc., a global cloud software and data analytics company for the…

1 year ago

A New Era of Customer-Centricity with IFF Pharma Solutions’ AnswerCenter Platform

Web-based customer platform provides answers at customers' fingertips NEW YORK, Dec. 12, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions announces the…

1 year ago

Novellia Data Shown to Optimize Risk Profiling to Inform HER2+ Breast Cancer Care

 -- New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of…

1 year ago

A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization

Modern commercial data helps organizations find new patients and HCPs PLEASANTON, Calif., Dec. 12, 2024 /PRNewswire/ -- Veeva Systems (NYSE:…

1 year ago

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL(R)

CDMO's Cell and Gene Center of Excellence Achieves fifth commercial viral vector product approval, and second overall from FDA in…

1 year ago

Phio Pharmaceuticals Announces Publication in Frontiers in Immunology

Journal is the official publication of the International Union of Immunological SocietiesMarlborough, Massachusetts--(Newsfile Corp. - December 12, 2024) - Phio…

1 year ago

Rancho BioSciences, LLC Awarded Great Place to Work(R) Certification for the Third Consecutive Year

Celebrating a Culture of Collaboration and a Mission to Save Lives Through Data SAN DIEGO, CALIFORNIA / ACCESSWIRE / December…

1 year ago

Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price

Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth…

1 year ago